KHRN Stock Overview
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Khiron Life Sciences Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.04 |
| 52 Week High | CA$0.17 |
| 52 Week Low | CA$0.035 |
| Beta | 3.15 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -65.22% |
| 3 Year Change | -91.92% |
| 5 Year Change | -95.88% |
| Change since IPO | -96.61% |
Recent News & Updates
Recent updates
Khiron Life Sciences Corp. (CVE:KHRN) Stock's 47% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Apr 17
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Khiron Life Sciences Corp.'s (CVE:KHRN) CEO For Now
Jun 24We're Keeping An Eye On Khiron Life Sciences' (CVE:KHRN) Cash Burn Rate
May 03What Type Of Returns Would Khiron Life Sciences'(CVE:KHRN) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Feb 06Shareholder Returns
| KHRN | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | 8.5% | -0.1% |
| 1Y | -65.2% | 49.5% | 6.2% |
Return vs Industry: KHRN underperformed the Canadian Pharmaceuticals industry which returned -32.9% over the past year.
Return vs Market: KHRN underperformed the Canadian Market which returned -0.8% over the past year.
Price Volatility
| KHRN volatility | |
|---|---|
| KHRN Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 15.2% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CA Market | 18.1% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: KHRN has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine KHRN's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | n/a | Alvaro Torres | khiron.ca |
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis.
Khiron Life Sciences Corp. Fundamentals Summary
| KHRN fundamental statistics | |
|---|---|
| Market cap | CA$9.30m |
| Earnings (TTM) | -CA$30.66m |
| Revenue (TTM) | CA$16.14m |
0.6x
P/S Ratio-0.3x
P/E RatioIs KHRN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KHRN income statement (TTM) | |
|---|---|
| Revenue | CA$16.14m |
| Cost of Revenue | CA$9.47m |
| Gross Profit | CA$6.67m |
| Other Expenses | CA$37.33m |
| Earnings | -CA$30.66m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.13 |
| Gross Margin | 41.34% |
| Net Profit Margin | -190.00% |
| Debt/Equity Ratio | 3.0% |
How did KHRN perform over the long term?
See historical performance and comparison